Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
53.91
+0.18 (+0.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Crispr Therapeutics Ag
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
3 Cathie Wood You’ll Regret Not Buying Soon: November 2023
November 16, 2023
Cathie Wood thinks we're out of the woods economically, and these stock picks in her portfolio stand to gain the most in coming months.
Via
InvestorPlace
Why Is NIO Stock Down 5% Today?
November 16, 2023
Nio stock is falling on Thursday as investors react to negative news following the summit between Presidents Xi Jinping and Joe Biden.
Via
InvestorPlace
Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug
November 16, 2023
The drug will sell under the brand name Casgevy in the UK for two blood diseases.
Via
Investor's Business Daily
What's Going On With Crispr Therapeutics Stock Thursday?
November 16, 2023
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene-
Via
Benzinga
Citi Is Souring on Plug Power (PLUG) Stock
November 16, 2023
Plug Power stock is falling on Thursday after the EV charging company's shares were hit with a downgrade and lowered price target from Citi.
Via
InvestorPlace
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
November 16, 2023
CRSP stock is up on U.K. authorization for its gene therapy treatment for sickle cell anemia. CRISPR hopes for FDA authorization next spring.
Via
InvestorPlace
Exposures
Product Safety
Why CRISPR Therapeutics Stock Could Be About to Take Off
November 08, 2023
CRISPR's financial prospects could soon get an upgrade.
Via
The Motley Fool
Why CRISPR Therapeutics Stock Charged Northward This Week
November 03, 2023
Gene correction technology took a big step forward this week.
Via
The Motley Fool
UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia
November 16, 2023
The U.K.
Via
Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
November 16, 2023
Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results.
Via
Benzinga
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
November 16, 2023
A few things put together could push the stock higher.
Via
The Motley Fool
Invest in the Future With These 7 Forever Stocks
November 15, 2023
Forever stocks are usually those predicting future trends. Finding them today means pinning down strong financials and prospects without FOMO.
Via
InvestorPlace
3 Biotech Stocks With Key Catalysts Coming in December
November 15, 2023
Some of the most exciting opportunities can be found in biotech stocks, especially if there's a powerful catalyst just around the corner.
Via
InvestorPlace
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
November 14, 2023
These stocks look reasonably priced today considering their long-term prospects.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
What's Going On With CRISPR Therapeutics Stock?
November 13, 2023
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Monday after Morgan Stanley maintained the company with an Underweight rating and lowered the price target. What To Know:
Via
Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
November 12, 2023
Investors should consider these "Goldilocks" biotech stocks to buy as they are poised to get significant boosts next year.
Via
InvestorPlace
1 No-Brainer Stock to Buy and Hold for 10 Years
November 11, 2023
This company has been in the news for much of the year.
Via
The Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
Investors shouldn't have to deliberate for too long about these great stocks.
Via
The Motley Fool
Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review
November 10, 2023
The major indexes ended long win streaks. Datadog led earnings winners.
Via
Investor's Business Daily
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
These three companies have gene editing therapies in late-stage clinical trials, making them promising biotech stocks to buy right now.
Via
InvestorPlace
This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues
November 09, 2023
Vertex shares look cheap today considering all the company has to offer.
Via
The Motley Fool
3 Biotech Stocks With the Strongest Clinical Pipelines
November 08, 2023
Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.
Via
InvestorPlace
CRISPR Therapeutics Stock Earns IBD Stock Rating Upgrade
November 08, 2023
On Wednesday, CRISPR Therapeutics stock had its Relative Strength (RS) Rating upgraded to 85, up from 68 a day earlier.
Via
Investor's Business Daily
Why CRISPR Therapeutics Stock Crushed the Market Today
November 07, 2023
Investors were cheered by the company's latest earnings release, coupled with operational updates.
Via
The Motley Fool
Vertex Slouches After Tech Leader Reports Mixed Results; But Late-Stage Pipeline In Focus
November 07, 2023
The company expects $9.85 billion in full-year sales of its cystic fibrosis treatments.
Via
Investor's Business Daily
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
November 06, 2023
Roku vaulted 50% to become Ark Innovation's top holding.
Via
Investor's Business Daily
Why CRISPR Therapeutics Stock Is Moving Higher Monday
November 06, 2023
CRISPR Therapeutics AG (NYSE: CRSP) shares are trading higher Monday after the company announced preclinical data for its investigational programs for the
Via
Benzinga
2 Magnificent Growth Stocks That Might Be Badly Mispriced Right Now
November 05, 2023
These two beaten-down growth stocks could be brilliant buys for risk-tolerant investors.
Via
The Motley Fool
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
November 03, 2023
The meeting went almost as well as could be expected.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.